HIT Consultant October 21, 2024
Jasmine Pennic

What You Should Know:

Waltz Health, a digital health company specializing in medication pricing and distribution, and Noom, a leader in digital health and chronic disease prevention, have announced a unique partnership to provide employers and health plans with a comprehensive and affordable weight loss program.

– The collaboration will leverage Waltz Connect, Waltz Health’s innovative platform, to streamline access to GLP-1 medications, making them more accessible and cost-effective for employees.

Addressing the Rising Cost of Obesity

Obesity is a significant health concern with substantial economic implications. Studies estimate that overweight and obese workers cost U.S. businesses and employees a staggering $425.5 billion annually. While GLP-1 drugs have proven effective in treating obesity and related cardiovascular issues,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
RNA editing: emerging from CRISPR’s shadow
Editas Medicine Seeks Partner for Ex Vivo Gene-Editing Program as Focus Turns to In Vivo R&D
Dotmatics aims to speed drug development, break data silos with Geneious Luma
1st sickle cell gene therapy patient completes treatment
Combining an Omnichannel Strategy with Benchmarking and Metrics to Engage Healthcare Professionals

Share This Article